CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter;s five force analysis
3.3.Key findings

3.3.1.Top Investment Pockets

3.4.Regulations
3.5.Market share analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Stringent government regulations regarding drug abuse
3.6.1.2.Rise in awareness against drug abuse
3.6.1.3.Surge in funding for drug screening

3.6.2.Restraints

3.6.2.1.Consideration of drug screening as a violation of rights
3.6.2.2.Negative impact of COVID-19 pandemic on the drug screening market

3.6.3.Opportunities

3.6.3.1.Development of novel drug screening tests
3.6.3.2.Tapping emerging markets

3.7.COVID-19 impact on the market

CHAPTER 4:DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Workplace drug testing

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Clinical toxicology testing

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Urine

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Oral fluid

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Hair

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Oil & gas

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Transportation

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Staffing

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

6.6.Government

6.6.1.Market size and forecast
6.6.2.Market analysis, by country

6.7.Other workplaces

6.7.1.Market size and forecast
6.7.2.Market analysis, by country

6.8.Hospital laboratories

6.8.1.Market size and forecast
6.8.2.Market analysis, by country

6.9.Clinical laboratories

6.9.1.Market size and forecast
6.9.2.Market analysis, by country

6.10.Other laboratories

6.10.1.Market size and forecast
6.10.2.Market analysis, by country

CHAPTER 7:DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. drug screening laboratory services market, by services
7.2.2.1.2.U.S. drug screening laboratory services market, by sample type
7.2.2.1.3.U.S. drug screening laboratory services market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada drug screening laboratory services market, by services
7.2.2.2.2.Canada drug screening laboratory services market, by sample type
7.2.2.2.3.Canada drug screening laboratory services market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico drug screening laboratory services market, by services
7.2.2.3.2.Mexico drug screening laboratory services market, by sample type
7.2.2.3.3.Mexico drug screening laboratory services market, by end user

7.2.3.North America market size and forecast, by services
7.2.4.North America market size and forecast, by sample type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany drug screening laboratory services market, by services
7.3.2.1.2.Germany drug screening laboratory services market, by sample type
7.3.2.1.3.Germany drug screening laboratory services market, by end user

7.3.2.2.France

7.3.2.2.1.France drug screening laboratory services market, by services
7.3.2.2.2.France drug screening laboratory services market, by sample type
7.3.2.2.3.France drug screening laboratory services market, by end user

7.3.2.3.UK

7.3.2.3.1.UK drug screening laboratory services market, by services
7.3.2.3.2.UK drug screening laboratory services market, by sample type
7.3.2.3.3.UK drug screening laboratory services market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy drug screening laboratory services market, by services
7.3.2.4.2.Italy drug screening laboratory services market, by sample type
7.3.2.4.3.Italy drug screening laboratory services market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain drug screening laboratory services market, by services
7.3.2.5.2.Spain drug screening laboratory services market, by sample type
7.3.2.5.3.Spain drug screening laboratory services market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe drug screening laboratory services market, by services
7.3.2.6.2.Rest of Europe drug screening laboratory services market, by sample type
7.3.2.6.3.Rest of Europe drug screening laboratory services market, by end user

7.3.3.Europe market size and forecast, by services
7.3.4.Europe market size and forecast, by sample type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan drug screening laboratory services market, BY SERVICES
7.4.2.1.2.Japan drug screening laboratory services market, by sample type
7.4.2.1.3.Japan drug screening laboratory services market, by end user

7.4.2.2.China

7.4.2.2.1.China drug screening laboratory services market, by services
7.4.2.2.2.China drug screening laboratory services market, by sample type
7.4.2.2.3.China drug screening laboratory services market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia drug screening laboratory services market, by services
7.4.2.3.2.Australia drug screening laboratory services market, by sample type
7.4.2.3.3.Australia drug screening laboratory services market, by end user

7.4.2.4.India

7.4.2.4.1.India drug screening laboratory services market, by services
7.4.2.4.2.India drug screening laboratory services market, by sample type
7.4.2.4.3.India drug screening laboratory services market, by end user

7.4.2.5.Rest of Asia-Pacific

7.4.2.5.1.Rest of Asia-Pacific drug screening laboratory services market, by services
7.4.2.5.2.Rest of Asia-Pacific drug screening laboratory services market, by sample type
7.4.2.5.3.Rest of Asia-Pacific drug screening laboratory services market, by end user

7.4.3.Asia-Pacific market size and forecast, by services
7.4.4.Asia-Pacific market size and forecast, by sample type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil drug screening laboratory services market, by services
7.5.2.1.2.Brazil drug screening laboratory services market, by sample type
7.5.2.1.3.Brazil drug screening laboratory services market, by end user

7.5.2.2.South Africa

7.5.2.2.1.South Africa drug screening laboratory services market, by services
7.5.2.2.2.South Africa drug screening laboratory services market, by sample type
7.5.2.2.3.South Africa drug screening laboratory services market, by end user

7.5.2.3.Saudi Arabia

7.5.2.3.1.Saudi Arabia drug screening laboratory services market, by services
7.5.2.3.2.Saudi Arabia drug screening laboratory services market, by sample type
7.5.2.3.3.Saudi Arabia drug screening laboratory services market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA drug screening laboratory services market, by services
7.5.2.4.2.Rest of LAMEA drug screening laboratory services market, by sample type
7.5.2.4.3.Rest of LAMEA drug screening laboratory services market, by end user

7.5.3.LAMEA market size and forecast, by services
7.5.4.LAMEA market size and forecast, by sample type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES (ALERE)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Business performance

8.2.QUEST DIAGNOSTICS INCORPORATED

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance

8.3.CLINICAL REFERENCE LABORATORY, INC

8.3.1.Company overview
8.3.2.Company snapshot

8.4.LABORATORY CORPORATION OF AMERICA HOLDINGS

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Business performance

8.5.STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS

8.5.1.Company overview
8.5.2.Company snapshot

8.6.ACM GLOBAL LABORATORIES, INC

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Key strategic moves and developments

8.7.OMEGA LABORATORIES LIMITED

8.7.1.Company overview
8.7.2.Company snapshot

8.8.PSYCHEMEDICS CORPORATION

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Business performance
8.8.5.Key strategic moves and developments

8.9.PRECISION DIAGNOSTICS

8.9.1.Company overview
8.9.2.Company snapshot

8.10.MILLENNIUM HEALTH

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Key strategic moves and developments

8.11.MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH

8.11.1.Company overview
8.11.2.Company snapshot